Table 2 Biochemical and hematological characteristics in patients with and without in-stent restenosis (ISR).

From: Monocyte to high-density lipoprotein cholesterol ratio predicts restenosis of drug-eluting stents in patients with unstable angina pectoris

 

Total

(n=474)

non-ISR

(n=250 )

ISR

(n=224)

P value

FBG (mmol/L)

5.31 (4.74, 6.63)

5.20 (4.73, 5.94)

5.59 (4.81, 7.21)

<0.001

TC (mmol/L)

4.56 ± 1.08

4.63 ± 1.06

4.48 ± 1.09

0.131

LDL (mmol/L)

2.96 ± 0.96

2.97 ± 0.97

2.95 ± 0.95

0.802

HDL (mmol/L)

1.08 ± 0.25

1.13 ± 0.25

1.02 ± 0.24

<0.001

TG (mmol/L)

1.52 (1.11, 2.11)

1.47 (1.11, 2.03)

1.57 (1.14, 2.16)

0.291

Creatinine (µmol/L)

71.51 ± 15.67

69.39 ± 15.13

73.87 ± 15.94

0.002

Uric acid (µmol/L)

318.69 ± 82.04

311.29 ± 80.00

327.37 ± 83.63

0.033

WBC (109/L)

6.86 ± 1.75

6.56 ± 1.59

7.20 ± 1.85

<0.001

Neutrophil (109/L)

4.52 ± 1.45

4.31 ± 1.33

4.75 ± 1.55

0.001

Lymphocyte (109/L)

1.81 ± 0.63

1.79 ± 0.63

1.83 ± 0.63

0.440

Monocyte (109/L )

4.10 ± 1.50

3.50 ± 1.20

4.70 ± 1.60

<0.001

Hs-CRP (mg/L)

1.33 (0.71, 3.24)

1.19 (0.70, 2.58)

1.90 (0.76, 4.54)

0.001

MHR

10.34 ± 4.68

8.46 ± 3.16

12.44 ± 5.19

<0.001

  1. DES Drug-eluting stent; ISR In-stent restenosis; FBG Fasting blood glucose; TC Total cholesterol; LDL Low-density lipoprotein; HDL High-density lipoprotein; TG Triglyceride; WBC White blood cell; hs-CRP High-sensitivity C-reactive protein; MHR Monocyte count to high-density lipoprotein cholesterol ratio.
Back to article page